Technivie

Active Ingredient(s): Ombitasavir + Paritaprevir + Ritonavir
FDA Approved: * July 24, 2015
Pharm Company: * ABBVIE INC
Category: Hepatitis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Technivie Overview

Ombitasvir/paritaprevir/ritonavir, sold under the brand name Technivie among others, is a medication used to treat hepatitis C.[1] It is a fixed-dose combination of ombitasvir, paritaprevir, and ritonavir.[1] Specifically it is used together with dasabuvir or ribavirin for cases caused by hepatitis C virus genotype 1 or 4.[1][2] Cure rates are around 95%.[2] It is taken by mouth.[1] It is generally...

Read more Technivie Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ombitasvir/paritaprevir/ritonavir

Recent Technivie Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ombitasavir + Paritaprevir + Ritonavir
  • Tablet: 12.5mg + 75mg + 50mg, 250mg + 12.5mg, 75mg, 50mg
  • Tablet, Extended Release: 200mg + 8.33mg + 50mg + 33.33mg
  • Tablet, Tablet: 12.5mg + 75mg + 50mg + 250mg, 250.0mg + 12.5mg + 75.0mg + 250mg,n/a,n/a,n/a + N/a,12.5mg,75mg,50mg, 250mg,n/a,n/a,n/a + N/a,12.5mg,75mg,50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Technivie: (1 result)

Sorted by National Drug Code

Drugs with one or more similar ingredients: (8 results)